Through Thick and Thin: Identifying Barriers to Bariatric Surgery, Weight Loss Maintenance, and Tailoring Obesity Treatment for the Future

Westerveld, Donevan; Yang, Dennis

doi:10.1155/2016/8616581

Cited by 47 publications

(44 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…43 Factors that may contribute to this statistic include physician attitudes, lack of resources, and cost burden. 71 The cost effectiveness of bariatric surgery is a controversial topic with some studies demonstrating that there were no reductions in health care-related costs in a bariatric surgery population compared with a nonsurgical control population. [72][73][74] Safety concerns may also play a significant role in patient willingness to undergo bariatric operations.…”

Section: Surgical Weight Loss Therapiesmentioning

confidence: 99%

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

Danda

Bailey

Weiss

2020

Digestive Disease Interventions

View full text Add to dashboard Cite

The obesity epidemic is a growing public health concern that has a severe effect on the health care system with significant morbidity, mortality, and cost. Treatment options for obesity include lifestyle modifications, pharmacotherapy, and bariatric surgery. Newer, less-invasive therapies including endoscopic bariatric procedures have been developed in recent years to fill the treatment gap that exists between noninvasive approaches and surgery. Bariatric artery embolization (BAE) is a novel minimally invasive endovascular procedure that has been developed to treat obesity. Recent evidence has suggested that bariatric embolization is well tolerated and can induce clinically significant weight loss through a hormonally mediated mechanism. This article will review existing preclinical and clinical data, and explore future directions of the endovascular treatment of obesity.

show abstract

Section: Surgical Weight Loss Therapiesmentioning

confidence: 99%

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

Danda

Bailey

Weiss

2020

Digestive Disease Interventions

View full text Add to dashboard Cite

show abstract

“…In addition, the stability of weight loss after surgery may be influenced by behavioral factors such as compliance to the new nutritional regimen and to an active lifestyle, as recommended by guidelines [ 10 , 11 , 21 , 22 ]. As for nutritional counselling, it was shown to be effective in attenuating weight regain after surgery [ 23 ].…”

Section: Introductionmentioning

confidence: 99%

An exercise-based educational and motivational intervention after surgery can improve behaviors, physical fitness and quality of life in bariatric patients

et al. 2020

View full text Add to dashboard Cite

Introduction Unhealthy lifestyles may hinder bariatric surgery outcomes. This non-randomized controlled study aimed to evaluate the effects of an integrated post-operative exercise-based educational and motivational program in improving behaviors, quality of life, anthropometric features, cardiorespiratory and physical fitness in bariatric patients respect to the only surgical intervention. Methods A group of adult sedentary bariatric patients chose to attend a 12-month exercise program integrated with diet education and motivational support, or to receive usual care. Dietary habits, binge eating disorder, physical activity, obesity-related quality of life, Body Mass Index, waist and hip circumference, VO 2 max, strength and flexibility were assessed at the start and at the end of the study in both groups. Results On a total of 82 patients enrolled, follow-up measures were obtained from 28 (85.7% females, mean age 38.2±8.7) and 42 (71.4% females, mean age 40.2±9.5) patients included in the intervention and control group, respectively. All the behavioral and physical outcomes improved significantly in the participants to the intervention, while the control group showed lesser changes, especially regarding quality of life and physical fitness. Conclusions Notwithstanding the self-selection, these results suggest that a timely postoperative behavioral multidisciplinary program for bariatric patients may be effective in establishing healthy behaviors which can lead to better surgery outcomes.

show abstract

“…The European Association for the Study of Obesity [12], The Obesity Society [13], and the American Association of Clinical Endocrinologists [14] guidelines all recommend bariatric surgery for individuals with a body mass index (BMI) ≥40 or ≥35 kg/m 2 with obesity-related comorbidities. Although the risk of major adverse outcomes with bariatric surgery are low [15], factors including patient and physican perceptions, lack of resources, and cost burden all act as barriers to utilization [16]. …”

Section: Introductionmentioning

confidence: 99%

Safety and tolerability of new-generation anti-obesity medications: a narrative review

Patel

Stanford

2018

Postgraduate Medicine

100

View full text Add to dashboard Cite

The prevalence of obesity and associated comorbidities is rising. Despite their weight-loss efficacy, new generation anti-obesity medications are only prescribed to a minority of adults with obesity, possibly, which in part may be due to safety concerns. This review presents detailed safety profiles for orlistat, phentermine/topiramate, lorcaserin, naltrexone/bupropion and liraglutide 3.0 mg, and discusses the associated risk–benefit profiles. Two anti-obesity medications presented safety issues that warranted further discussion; phentermine/topiramate (fetal toxicity) and liraglutide 3.0 mg (risk of gallstone disease and mild, acute pancreatitis), whereas the adverse events associated with orlistat, lorcaserin, and naltrexone/bupropion were mostly transient tolerability issues. The difficulties surrounding the objective determination of risk–benefit for anti-obesity medications is discussed. The need for more long-term data, thorough patient assessment, individualization of pharmacological interventions and adherence to stopping rules to maximize risk–benefit are highlighted. Overall, the majority of new generation anti-obesity medications present encouraging tolerability profiles; however, in some cases a lack of long-term clinical trials confounds the accurate determination of risk–benefit.

show abstract

Through Thick and Thin: Identifying Barriers to Bariatric Surgery, Weight Loss Maintenance, and Tailoring Obesity Treatment for the Future

Cited by 47 publications

References 59 publications

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

An exercise-based educational and motivational intervention after surgery can improve behaviors, physical fitness and quality of life in bariatric patients

Safety and tolerability of new-generation anti-obesity medications: a narrative review

Contact Info

Product

Resources

About